• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

The FDA is considering an over-the-counter birth control pill for the first time ever
Health
The FDA is considering an over-the-counter birth control pill for the first time ever
By Matthew Perrone and The Associated PressMay 5, 2023
FDA signals the growing recognition of the gut in health by approving the first fecal transplant pill
Health
FDA signals the growing recognition of the gut in health by approving the first fecal transplant pill
By Matthew Perrone and The Associated PressApril 26, 2023
FDA
Health
First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By Matthew Perrone and The Associated PressApril 25, 2023
Conflicting court rulings put access to widely-used abortion pill mifepristone into question
Health
Conflicting court rulings put access to widely-used abortion pill mifepristone into question
By Paul J. Weber, Matthew Perrone and The Associated PressApril 7, 2023
Makena
Health
FDA orders immediate withdrawal of only drug approved for preterm birth prevention
By Matthew Perrone and The Associated PressApril 6, 2023
Unproven birth drug that symbolized the FDA’s struggle to pull drugs from the market is finally withdrawn
Health
Unproven birth drug that symbolized the FDA’s struggle to pull drugs from the market is finally withdrawn
By Matthew Perrone and The Associated PressMarch 8, 2023
The FDA is using YouTube and Twitter to try and tackle ‘a leading cause of death in America’: Online misinformation
Health
The FDA is using YouTube and Twitter to try and tackle ‘a leading cause of death in America’: Online misinformation
By Matthew Perrone and The Associated PressFebruary 21, 2023
New lawsuits target abortion pill restrictions in North Carolina and West Virginia
Politics
New lawsuits target abortion pill restrictions in North Carolina and West Virginia
By Matthew Perrone and The Associated PressJanuary 26, 2023
U.S. proposes streamlining COVID vaccinations by making them once-a-year—like a flu shot
Health
U.S. proposes streamlining COVID vaccinations by making them once-a-year—like a flu shot
By Matthew Perrone and The Associated PressJanuary 23, 2023
FDA Commissioner Robert Califf
Health
The first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
Joe Biden
Health
The FDA just finalized a Biden rule change to make abortion pills much more widely available at pharmacies nationwide
By Matthew Perrone and The Associated PressJanuary 4, 2023
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
Health
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By Matthew Perrone and The Associated PressDecember 18, 2022
FDA
Health
The FDA’s speedy approval of experimental new drugs came to a screeching halt this year
By Matthew Perrone and The Associated PressDecember 7, 2022
Man with IV
Health
If you have hemophilia, you can now get a one-time gene therapy for $3.5 million
By Matthew Perrone and The Associated PressNovember 23, 2022
Juul
Retail
Layoffs aren’t just hitting tech. Juul is eliminating hundreds of jobs.
By Matthew Perrone and The Associated PressNovember 10, 2022
1...
  • 3
  • 4
  • 5
  • 6
  • 7
8
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.